vs
阿普塔集团（ATR）与Vestis Corp（VSTS）财务数据对比。点击上方公司名可切换其他公司
阿普塔集团的季度营收约是Vestis Corp的1.5倍（$962.7M vs $663.4M），阿普塔集团净利率更高（7.7% vs -1.0%，领先8.7%），阿普塔集团同比增速更快（13.5% vs -3.0%），阿普塔集团自由现金流更多（$96.9M vs $28.3M），过去两年阿普塔集团的营收复合增速更高（2.6% vs -3.0%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
Vestis Corp是北美领先的工作制服、安全防护服饰及配套设施服务供应商，服务覆盖医疗、制造、零售、餐饮住宿、公共服务等多个领域，为企业客户提供定制化的制服租赁、清洁与日常维护解决方案。
ATR vs VSTS — 直观对比
营收规模更大
ATR
是对方的1.5倍
$663.4M
营收增速更快
ATR
高出16.5%
-3.0%
净利率更高
ATR
高出8.7%
-1.0%
自由现金流更多
ATR
多$68.6M
$28.3M
两年增速更快
ATR
近两年复合增速
-3.0%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $663.4M |
| 净利润 | $74.3M | $-6.4M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | 2.5% |
| 净利率 | 7.7% | -1.0% |
| 营收同比 | 13.5% | -3.0% |
| 净利润同比 | -26.4% | -868.1% |
| 每股收益（稀释后） | $1.13 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRVSTS
| Q1 26 | — | $663.4M | ||
| Q4 25 | $962.7M | $712.0M | ||
| Q3 25 | $961.1M | — | ||
| Q2 25 | $966.0M | $673.8M | ||
| Q1 25 | $887.3M | $665.2M | ||
| Q4 24 | $848.1M | $683.8M | ||
| Q3 24 | $909.3M | $684.3M | ||
| Q2 24 | $910.1M | $698.2M |
净利润ATRVSTS
| Q1 26 | — | $-6.4M | ||
| Q4 25 | $74.3M | $-12.5M | ||
| Q3 25 | $127.9M | — | ||
| Q2 25 | $111.7M | $-676.0K | ||
| Q1 25 | $78.8M | $-27.8M | ||
| Q4 24 | $100.9M | $832.0K | ||
| Q3 24 | $100.0M | $-2.3M | ||
| Q2 24 | $90.5M | $5.0M |
营业利润率ATRVSTS
| Q1 26 | — | 2.5% | ||
| Q4 25 | 11.0% | 2.5% | ||
| Q3 25 | 14.2% | — | ||
| Q2 25 | 14.9% | 3.7% | ||
| Q1 25 | 12.8% | -1.3% | ||
| Q4 24 | 14.2% | 4.4% | ||
| Q3 24 | 15.2% | 4.4% | ||
| Q2 24 | 13.8% | 5.4% |
净利率ATRVSTS
| Q1 26 | — | -1.0% | ||
| Q4 25 | 7.7% | -1.8% | ||
| Q3 25 | 13.3% | — | ||
| Q2 25 | 11.6% | -0.1% | ||
| Q1 25 | 8.9% | -4.2% | ||
| Q4 24 | 11.9% | 0.1% | ||
| Q3 24 | 11.0% | -0.3% | ||
| Q2 24 | 9.9% | 0.7% |
每股收益（稀释后）ATRVSTS
| Q1 26 | — | $-0.05 | ||
| Q4 25 | $1.13 | $-0.10 | ||
| Q3 25 | $1.92 | — | ||
| Q2 25 | $1.67 | $-0.01 | ||
| Q1 25 | $1.17 | $-0.21 | ||
| Q4 24 | $1.48 | $0.01 | ||
| Q3 24 | $1.48 | $-0.02 | ||
| Q2 24 | $1.34 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $41.5M |
| 总债务越低越好 | $1.1B | — |
| 股东权益账面价值 | $2.7B | $864.4M |
| 总资产 | $5.3B | $2.9B |
| 负债/权益比越低杠杆越低 | 0.43× | — |
8季度趋势，按日历期对齐
现金及短期投资ATRVSTS
| Q1 26 | — | $41.5M | ||
| Q4 25 | $409.5M | $29.7M | ||
| Q3 25 | $264.8M | — | ||
| Q2 25 | $169.8M | $23.7M | ||
| Q1 25 | $136.8M | $28.8M | ||
| Q4 24 | $226.2M | $18.6M | ||
| Q3 24 | $327.9M | $31.0M | ||
| Q2 24 | $223.9M | $29.1M |
总债务ATRVSTS
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $1.2B | ||
| Q3 25 | $546.0M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $561.2M | — | ||
| Q4 24 | $688.1M | — | ||
| Q3 24 | $822.7M | $1.2B | ||
| Q2 24 | $681.5M | — |
股东权益ATRVSTS
| Q1 26 | — | $864.4M | ||
| Q4 25 | $2.7B | $865.6M | ||
| Q3 25 | $2.8B | — | ||
| Q2 25 | $2.7B | $882.2M | ||
| Q1 25 | $2.5B | $876.3M | ||
| Q4 24 | $2.5B | $899.6M | ||
| Q3 24 | $2.5B | $903.1M | ||
| Q2 24 | $2.4B | $901.2M |
总资产ATRVSTS
| Q1 26 | — | $2.9B | ||
| Q4 25 | $5.3B | $2.9B | ||
| Q3 25 | $5.1B | — | ||
| Q2 25 | $4.9B | $2.9B | ||
| Q1 25 | $4.5B | $2.9B | ||
| Q4 24 | $4.4B | $2.9B | ||
| Q3 24 | $4.6B | $2.9B | ||
| Q2 24 | $4.5B | $3.1B |
负债/权益比ATRVSTS
| Q1 26 | — | — | ||
| Q4 25 | 0.43× | 1.35× | ||
| Q3 25 | 0.20× | — | ||
| Q2 25 | 0.20× | — | ||
| Q1 25 | 0.22× | — | ||
| Q4 24 | 0.28× | — | ||
| Q3 24 | 0.32× | 1.29× | ||
| Q2 24 | 0.28× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $37.7M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $28.3M |
| 自由现金流率自由现金流/营收 | 10.1% | 4.3% |
| 资本支出强度资本支出/营收 | 9.0% | 1.4% |
| 现金转化率经营现金流/净利润 | 2.47× | — |
| 过去12个月自由现金流最近4个季度 | $299.6M | $45.0M |
8季度趋势，按日历期对齐
经营现金流ATRVSTS
| Q1 26 | — | $37.7M | ||
| Q4 25 | $183.7M | $30.9M | ||
| Q3 25 | $177.6M | — | ||
| Q2 25 | $126.0M | $22.9M | ||
| Q1 25 | $82.7M | $6.7M | ||
| Q4 24 | $178.2M | $3.8M | ||
| Q3 24 | $229.3M | $295.6M | ||
| Q2 24 | $143.6M | $48.7M |
自由现金流ATRVSTS
| Q1 26 | — | $28.3M | ||
| Q4 25 | $96.9M | $15.6M | ||
| Q3 25 | $114.3M | — | ||
| Q2 25 | $62.5M | $8.0M | ||
| Q1 25 | $25.9M | $-6.9M | ||
| Q4 24 | $112.2M | $-11.0M | ||
| Q3 24 | $162.7M | $267.5M | ||
| Q2 24 | $75.4M | $27.7M |
自由现金流率ATRVSTS
| Q1 26 | — | 4.3% | ||
| Q4 25 | 10.1% | 2.2% | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | 6.5% | 1.2% | ||
| Q1 25 | 2.9% | -1.0% | ||
| Q4 24 | 13.2% | -1.6% | ||
| Q3 24 | 17.9% | 39.1% | ||
| Q2 24 | 8.3% | 4.0% |
资本支出强度ATRVSTS
| Q1 26 | — | 1.4% | ||
| Q4 25 | 9.0% | 2.2% | ||
| Q3 25 | 6.6% | — | ||
| Q2 25 | 6.6% | 2.2% | ||
| Q1 25 | 6.4% | 2.0% | ||
| Q4 24 | 7.8% | 2.2% | ||
| Q3 24 | 7.3% | 4.1% | ||
| Q2 24 | 7.5% | 3.0% |
现金转化率ATRVSTS
| Q1 26 | — | — | ||
| Q4 25 | 2.47× | — | ||
| Q3 25 | 1.39× | — | ||
| Q2 25 | 1.13× | — | ||
| Q1 25 | 1.05× | — | ||
| Q4 24 | 1.77× | 4.54× | ||
| Q3 24 | 2.29× | — | ||
| Q2 24 | 1.59× | 9.66× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
VSTS
| Workplace Supplies | $375.2M | 57% |
| Uniforms | $227.7M | 34% |
| Other | $60.5M | 9% |
